Pathos
Pathos is a biotech company leveraging AI and large language models to revolutionize oncology drug development. They focus on building a cancer-specific foundation model trained on unique datasets, collaborating with clinical researchers to optimize trial design and patient matching, aiming to improve outcomes and accelerate therapies to patients.
Headquarters
New York, New York, United States
Company Size
11-50 employees
Founded
2022
Pathos is an AI-enabled, clinical-stage biotech company redefining drug development for precision oncology. The company integrates advanced AI technology, biological modeling, and the largest collection of multimodal oncology patient data to make clinical trials smarter, faster, and more precise. By identifying the right patient populations and building a repeatable development engine, Pathos aims to reduce trial failures and accelerate the delivery of precision therapies through biopharma partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pathos.
86% above the average for this role